CCDC169 is a coiled-coil domain-containing protein located on chromosome 13 with emerging relevance in cancer biology. While its specific molecular function remains insufficiently characterized in the provided literature, CCDC169 has been identified as part of functionally related gene clusters involved in gamete functions 1. In cancer contexts, CCDC169 shows copy number-dependent regulation: it is significantly upregulated when chromosome 13 is gained, as demonstrated in colorectal cancer models where extra copies of chromosome 13 resulted in reproducible upregulation of CCDC169 transcripts alongside six other genes in the 13q13 cluster 2. Clinical significance emerges from prognostic studies identifying CCDC169 mutations (as part of the CCDC169-SOHLH2 fusion or locus) within a five-gene predictive panel for gastric cancer recurrence, where mutations in these genes correlated positively with improved patient survival and achieved an ROC-AUC of 0.813 for predicting recurrence 3. However, the mechanistic basis for CCDC169's protective association in gastric cancer and its role in normal physiology requires further investigation. CCDC169 likely serves as a potential biomarker for cancer prognosis, though functional studies are needed to establish direct causal relationships.